thyroid stimulating hormone (tsh) using radiolabelled and for the diagnosis and therapy of differentiated thyroid cancer.

摘要

The invention relates to the use of the human recombinant thyroid stimulating hormone (TSH) labelled with radioisotopes suitable for the administration in vivo, having a good stability and specific activity, as scintigraphic tracer and/or as radiomedicament respectively for the diagnosis and therapy of differentiated thyroid tumors and the respective metastases.